LONGEVITY & CELLULAR RESEARCH

SS-31

Studied for protecting the mitochondria—the cell's energy factories—and reducing oxidative stress.

SS-31 (elamipretide) is a short peptide that concentrates inside the mitochondria, the structures that generate a cell's energy. It is studied for protecting mitochondrial function, reducing oxidative stress, and supporting cellular energy, and has been evaluated in clinical trials for mitochondrial conditions.

Mitochondria-TargetedCardiolipin BindingOxidative StressCellular Energy

Why BLP features SS-31

Included because it has a highly specific, well-characterized mitochondrial mechanism and has been evaluated in human clinical trials for mitochondrial conditions. Its real-world use history is still developing, placing it as an emerging longevity-research compound with strong mechanistic backing.

Mechanism

Selectively binds cardiolipin, a fat unique to the inner mitochondrial membrane, which is what concentrates it exactly where it acts.

Stabilizes mitochondrial structure and keeps the energy-production machinery correctly assembled.

Increases ATP output while reducing the reactive byproducts that damage cells—and is described as leaving healthy mitochondria unaffected.

WHAT THE RESEARCH MEASURED

Research findings

Findings describe study outcomes, not expected personal results.

Human research findings

  • Clinical research (as elamipretide) has evaluated mitochondrial function and exercise tolerance.
  • Reported reduction in mitochondrial oxidative-stress markers.
  • Reported enhanced cellular energy and reduced fatigue in models of aging and dysfunction.
  • Mostly well tolerated; rare mild injection-site reactions, fatigue, or headache.

Mechanistic & supporting research

  • Cardiolipin-targeting mechanism very well characterized.
  • Mitochondrial-protection effects documented in preclinical and clinical research.

Regulatory status

SS-31 (elamipretide) is investigational and not FDA-approved. Sold and offered strictly for laboratory and research use.